Factor V Leiden deficiency

Introduction to Factor V Leiden

Welcome to the Factor V Leiden subsection of the Haematology for the MSRA course.

This section is designed to provide comprehensive and structured learning materials to help you understand and master the topic of Factor V Leiden for the MSRA.


Resources for Factor V Leiden:

  1. Factor V Leiden Revision Notes for MSRA: Detailed and concise traditional revision notes covering all essential aspects of Factor V Leiden, including its causes, symptoms, diagnosis, and treatment. These notes are designed using UK NICE guidelines. Use the notes to gain an initial understanding of the topic.
  2. Factor V Leiden Flashcards for MSRA: Interactive flashcards to help you memorise key facts and concepts about Factor V Leiden. These are perfect for quick reviews and reinforcing your knowledge.
  3. Factor V Leiden Accordion Q&A Notes for the MSRA: A unique feature where you can test your understanding of Factor V Leiden with question-and-answer style revision notes. This format helps in active learning and retention of important information.
  4. Factor V Leiden Rapid Fire Quiz for MSRA: A short quiz to test your knowledge and recall of Factor V Leiden-related concepts. This is an excellent way to assess your progress and identify areas that need further review.

We hope you find these resources helpful and engaging as you prepare for the MSRA.


Key Points about Factor V Leiden

  • Definition: Factor V Leiden is a genetic mutation that increases the risk of developing abnormal blood clots, particularly venous thromboembolism (VTE).
  • Causes:
    • Inherited mutation in the F5 gene that affects blood clotting.
    • Autosomal dominant inheritance pattern.
  • Symptoms:
    • Increased risk of deep vein thrombosis (DVT) and pulmonary embolism (PE).
    • Symptoms of DVT include leg swelling, pain, and redness.
    • Symptoms of PE include shortness of breath, chest pain, and coughing up blood.
  • Investigations:
    • Blood tests for activated protein C resistance.
    • Genetic testing to confirm the presence of the Factor V Leiden mutation.
    • Imaging for diagnosis of thromboembolic events, such as Doppler ultrasound or CT pulmonary angiography.
  • Management:
    • Anticoagulation therapy (e.g., warfarin, direct oral anticoagulants) to reduce the risk of clotting.
    • Long-term anticoagulation in cases of recurrent VTE.
    • Lifestyle modifications including smoking cessation and weight management.
  • Complications:
    • Increased risk of recurrent thromboembolic events.
    • Risk of anticoagulant-related bleeding.
    • Potential complications during pregnancy, including miscarriage and preeclampsia.

#MSRA #MSRARevisionNotes #MSRATextbook #MSRAQuiz #MSRAQuestionBank #MSRAFlashcards #MSRAQ&ANotes #MSRAAccordions #MultiSpecialityRecruitmentAssessment #MSRAOnlineRevision #MSRARevisionWebsite #FactorVLeiden #Haematology #HaematologyforMSRA

Free MSRA Podcast: Factor V Leiden

https://open.spotify.com/episode/3PjndnRSYTuDHlEM6OY24E?si=tZ-JtR9JRqGxvk-RYsVqtg